National Institute on Drug Abuse; Amended Notice of Meeting

---
identifier: "/us/fr/2023-19406"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute on Drug Abuse; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2023-19406"
section_name: "National Institute on Drug Abuse; Amended Notice of Meeting"
positive_law: false
currency: "2023-09-08"
last_updated: "2023-09-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
document_number: "2023-19406"
document_type: "notice"
publication_date: "2023-09-08"
agencies:
  - "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
  - "National Institutes of Health"
---


#  National Institute on Drug Abuse; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Advisory Council on Drug Abuse, September 12, 2023, 10:30 a.m. to September 12, 2023, 05:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 which was published in the *Federal Register* on August 21, 2023, FR Doc 2023-17889, 88 FR 56847.

This notice is being amended to change the open session start time from 12:45 p.m. to 1:00 p.m. The open session will now be held from 1:00 p.m. to 5:00 p.m. on September 12, 2023. The meeting is partially closed to the public.

Dated: September 1, 2023.

Tyeshia M. Roberson-Curtis,

Program Analyst, Office of Federal Advisory Committee Policy.